xiuzhen group acquires bnct technology project
2024-09-13
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
beijing news reported that on september 10, xiu laigui, chairman of xiuzhen group, and xiu yuan, president of xiuzhen group, together with some senior executives, met with relevant leaders of japan fushimi holdings group in japan, acquired the bnct (accelerator boron neutron capture therapy experimental device) technology project, and participated in the bnct groundbreaking ceremony.
bnct, as one of the most cutting-edge technologies in the field of international cancer treatment, has demonstrated significant advantages of precision, high efficiency and minimal damage to normal tissues due to its unique boron neutron capture therapy principle. with the increasing number of cancer patients worldwide and their growing demand for high-quality survival, the market demand and application prospects of bnct are becoming increasingly broad.
xiuzhen group said that this cooperation will open a new era for xiuzhen group's bnct business. it hopes that through the deepening of this exchange and cooperation, it will devote itself to the application and expansion of bnct, so that advanced treatment methods can relieve the pain of more cancer patients and bring new hope to patients' families. at the same time, it also hopes to use this cooperation as an opportunity to introduce bnct, an international cutting-edge technology, into china and promote its clinical application and popularization.
proofread by liu baoqing
